Evidence map›Paper›PMID 41136732›Full record

ArticleNature microbiology2025

Bacterial TIR-based immune systems sense phage capsids to initiate defense.

Cameron G Roberts, Chloe B Fishman, Zhiying Zhang, Dalton V Banh, Dinshaw J Patel, Luciano A Marraffini

Abstract read
In one paragraph

Article in Nature microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. How bacterial immune systems sense phage infection.Nature reviews. Microbiology · 2026
    Review
  3. Article
  4. Review
  5. Balancing of immune activation and suppression during phage infection.bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Cameron G Roberts *Laboratory of Bacteriology, The Rockefeller University, New York, NY, USA. croberts@rockefeller.edu.ORCID http://orcid.org/0000-0002-0115-7013
Chloe B Fishman *Laboratory of Bacteriology, The Rockefeller University, New York, NY, USA.
Zhiying ZhangStructural Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Dalton V BanhLaboratory of Bacteriology, The Rockefeller University, New York, NY, USA.ORCID http://orcid.org/0000-0001-8167-9358
Dinshaw J PatelStructural Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-9779-7778
Luciano A MarraffiniLaboratory of Bacteriology, The Rockefeller University, New York, NY, USA. marraffini@rockefeller.edu.ORCID http://orcid.org/0000-0002-9163-0969

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Weill Cornell/Rockefeller/Sloan Kettering MST ProgramT32GM152349 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI KATHARINE C HSU · 2024 to 2026
$6.6M
Immunity and Infectious DiseaseT32AI070084 · NIAID · ROCKEFELLER UNIVERSITY · PI Michel C Nussenzweig · 2008 to 2026
$3.3M
Development of small molecule cGAS inhibitors for repression of dsDNA-triggered interferon expressionR01AI141507 · NIAID · ROCKEFELLER UNIVERSITY · PI TUSCHL, THOMAS · 2019 to 2022
$2.1M
'Class I and III Multi-subunit CRISPR-Cas Surveillance Complexes: Recognition, Cleavage, Autoimmunity and Inhibition’R01GM129430 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI PATEL, DINSHAW J · 2019 to 2022
$1.4M
Structure-Activity Based Mechanistic Insights into Cleavage Chemistry by Self-Cleaving Nucleolytic RibozymesR01GM145888 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI PATEL, DINSHAW J · 2022 to 2025
$1.3M
Elucidating how CRISPR-Cas Modulates the Spread of S. aureus Pathogenicity IslandsF30AI157535 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI BANH, DALTON VAN · 2021 to 2024
$203k
NCI NIH HHS P30 CA008748NIAID NIH HHS F30 AI157535NIAID NIH HHS R01 AI141507NIAID NIH HHS T32 AI070084NIGMS NIH HHS R01 GM129430NIGMS NIH HHS R01 GM145888NIGMS NIH HHS T32 GM152349U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI141507U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) GM129430U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) GM145888
6 · The paper itself

Abstract

Thoeris systems use proteins with Toll/interleukin-1 receptor domains to protect prokaryotes from phage infection through the synthesis of a cyclic adenosine diphosphate ribose signalling molecule, which activates an effector that depletes the host of the essential metabolite NAD

Indexed as

Bacterial ProteinsBacteriophagesCapsidCapsid ProteinsReceptors, Interleukin-1Staphylococcus aureusHumansImmunity, InnateBacterial ProteinsCapsid ProteinsReceptors, Interleukin-1

Identifiers

PMID41136732
PMCPMC12578639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.